Share

July 21, 2020; 95 (3) Views & Reviews

Preserving stroke care during the COVID-19 pandemic

Potential issues and solutions

Enrique C. Leira, Andrew N. Russman, José Biller, Devin L. Brown, Cheryl D. Bushnell, Valeria Caso, Angel Chamorro, Claire J. Creutzfeldt, Salvador Cruz-Flores, Mitchell S.V. Elkind, Pierre Fayad, Michael T. Froehler, Larry B. Goldstein, Nicole R. Gonzales, Brian Kaskie, Pooja Khatri, Sarah Livesay, David S. Liebeskind, Jennifer J. Majersik, Asma M. Moheet, Jose G. Romano, Nerses Sanossian, Lauren H. Sansing, Brian Silver, Alexis N. Simpkins, Wade Smith, David L. Tirschwell, David Z. Wang, Dileep R. Yavagal, Bradford B. Worrall
First published May 8, 2020, DOI: https://doi.org/10.1212/WNL.0000000000009713
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
572

Share

Article Information

vol. 95 no. 3 124-133
DOI: 
https://doi.org/10.1212/WNL.0000000000009713
PubMed: 
32385186
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 8, 2020
  • Accepted in final form April 29, 2020
  • First Published May 8, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Enrique C. Leira, MD, MS,
    2. Andrew N. Russman, DO,
    3. José Biller, MD,
    4. Devin L. Brown, MD,
    5. Cheryl D. Bushnell, MD,
    6. Valeria Caso, MD, PhD,
    7. Angel Chamorro, MD, PhD,
    8. Claire J. Creutzfeldt, MD,
    9. Salvador Cruz-Flores, MD, MPH,
    10. Mitchell S.V. Elkind, MD, MS,
    11. Pierre Fayad, MD,
    12. Michael T. Froehler, MD, PhD,
    13. Larry B. Goldstein, MD,
    14. Nicole R. Gonzales, MD,
    15. Brian Kaskie, PhD,
    16. Pooja Khatri, MD, MSc,
    17. Sarah Livesay, DNP, ARNP,
    18. David S. Liebeskind, MD,
    19. Jennifer J. Majersik, MD,
    20. Asma M. Moheet, MD, MHDS,
    21. Jose G. Romano, MD,
    22. Nerses Sanossian, MD,
    23. Lauren H. Sansing, MD, MS,
    24. Brian Silver, MD,
    25. Alexis N. Simpkins, MD, PhD, MS,
    26. Wade Smith, MD, PhD,
    27. David L. Tirschwell, MD, MSc,
    28. David Z. Wang, DO,
    29. Dileep R. Yavagal, MD and
    30. Bradford B. Worrall, MD, MSc
  1. Enrique C. Leira, MD, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. US patent Application N0 16/783,003 pending: SYSTEMS, METHODS AND DEVICES FOR LOW FREQUENCY VIBRATION AND SYNERGISTIC THROMBOLYTIC INFUSION ON SUBJECTS WITH ISCHEMIC STROKE OR IN NEED OF THROMBOLYSIS (filed by University of Iowa. EC Leira inventor) Not relevant to this manuscript

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH-NINDS U10NS086521-01 “The University of Iowa's Statewide Stroke Research Network” Role: Principal Investigator. 10/2013-ONGOING R21 NS104579

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Andrew N. Russman, DO,
    3. Scientific Advisory Boards:

    1. (1) Portola Pharmaceuticals

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1)Boston Scientific Corp.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. José Biller, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editor of Journal of Stroke and Cerebrovascular DiseasesStroke Editorial Board Member of Up-To-Date

    Patents:

    1. NONE

    Publishing Royalties:

    1. Practical Neurology 5th Edition, Wolters Kluwers, 2017 Localization in Clinical Neurology 7th Edition, Wolters Kluwers, 2017 The Hospital Neurologist, McGraw Hill, 2017 The Neurologic Examination 7th Edition, McGraw Hill, 2017 Primer on Cerebrovascular Diseases 2nd Edition, Elsevier, 2017 Uncommon Causes of Stroke 3rd Edition, Cambridge Medicine 2018

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Devin L. Brown, MD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. University of Washington; American Heart Association

    Editorial Boards:

    1. Neurology, editorial board member, 2008-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NHLBI, R01HL123379, M-PI, 04/17/15 - 03/31/19 NHLBI, R01HL126700, M-PI, 12/15/15 - 11/30/19 NINDS, U24NS107214, M-PI, 08/14/18 - 07/31/23 NINDS, U01NS099043, M-PI, 08/15/18 - 07/31/24 NIMHD, R01MD011516, Co-I, 07/14/17 - 02/28/21 NINDS, R01NS038916, Co-I, 02/01/09 - 03/31/24

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Cheryl D. Bushnell, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Stroke in Women, Henry Stewart Talks, 2007-2020 Neurological Diseases and Pregnancy, Oxford University, 2019- present

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Patient Centered Outcomes Research Institute PCA-1403-14532, COMprehensive Post-Acute Stroke Services pragmatic trial; role: co-PI, 3 years Affordability and Efficiency for COMprehensive Post-Acute Stroke Services (COMPASS); AHRQ R01HS025723-01, role: co-PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. 1) Care Directions, LLC, No compensation since startup.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Valeria Caso, MD, PhD,
    7. Scientific Advisory Boards:

    1. Respect ESUS Bayer SPI

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Daichi-Sankyo BI Servier

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Daichi-Sankyo BI Servier bms

    Speakers' Bureaus:

    1. speaker’s bureau of Boehringer Ingelheim, Bayer, daichi- Sankyo, Ever Pharma

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Angel Chamorro, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. “Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid” Nº of patent: No. 2012-0502476 Country of inscription: Germany, UK, France, Italy

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Dr Chamorro owns stock in FreeOx Biotech SL. This SME is committed to test the therapeutic value of the administration of uric acid in patients with acute ischemic stroke

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Claire J. Creutzfeldt, MD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Career Development Award NINDS K23 NS099421-01A1 07/2018-07/2022

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Cambia Health Foundation's Sojourn Scholars Program

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Salvador Cruz-Flores, MD, MPH,
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. AAN: funding for travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NovoNordisk CEC member Duke University CEC member Galapagos CEC member

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Mitchell S.V. Elkind, MD, MS,
    11. Scientific Advisory Boards:

    1. Vascular Dynamics, interventional treatment for hypertension (2018-2019)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Stroke, Editor of International Stroke Early Career and Training Section, published by AHA (2017-2019)

    Patents:

    1. NONE

    Publishing Royalties:

    1. UpToDate, 2015-2020, chapters on cryptogenic stroke and hemicraniectomy for acute stroke

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Abbott, consulting regarding cryptogenic stroke (2017-2018)

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) American Heart Association National Board of Directors (2014-2022); (2) American Heart Association Founders Affiliate Board of Directors(2008-2016); (2) American Heart Association NY City Board of Directors (2011-2017)

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) BMS-Pfizer Alliance, provides drug in kind for support of clinical trial of aspirin vs apixaban for cryptogenic stroke; (2) Roche, provides lab support for support of clinical trial of aspirin vs apixaban for cryptogenic stroke and stroke (2014-2016)

    Research Support, Government Entities:

    1. (1) NIH/NINDS R01 29993, PI, 2007-2020(2) NIH/NINDS U01 NS095869, PI, ARCADIA, 2017-2022

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Pierre Fayad, MD,
    12. Scientific Advisory Boards:

    1. (1) Medtronic (2) Portola

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Michael T. Froehler, MD, PhD,
    13. Scientific Advisory Boards:

    1. 1. Medtronic 2. Genentech 3. Viz.ai 4. Balt USA 5.Stryker 6. Cerenovus 7. Corindus 8. EndoPhys

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Medtronic 2. Genentech 3. Viz.ai 4. Balt USA 5.Stryker 6. Cerenovus 7. Corindus 8. EndoPhys

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1. Stryker 2. Medtronic 3. Microvention 4. Penumbra 5. EndoPhys 6. Genentech

    Research Support, Government Entities:

    1. NIH - NINDS. The grant number(s) should not be listed, as this funding is irrelevant to the current work.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Larry B. Goldstein, MD,
    14. Scientific Advisory Boards:

    1. Comercial - Shin Poong Pharmaceuticals

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Comercial - Shin Poong Pharmaceuticals

    Editorial Boards:

    1. 1. Stroke, Editorial Board, 2002- 2. Neurology, Editorial Board, 2003 – 3. Cerebrovascular Diseases, Editorial Board, 2004 - (Associate Editor 2012-) 4. Journal of Stroke and Cerebrovascular Disease (Editorial Board) 5. Cardiology Today, Editorial Board, 2011- No compensation

    Patents:

    1. Test for amylin deposition.

    Publishing Royalties:

    1. 1. Screening for Asymptomatic Carotid Stenosis, Up-to-Date, 2007- 2. Use and Utility of Stroke Scales and Grading Sysytems, Up-to- Date, 2005-

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Comercial- Shin Poong Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. NIH, Stroke Hospitalization in Elderly with Medicare, Consultant 2. NIH, Small Vessel Disease Biomarkers in a Longitudinally-Followed

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Heart Association - Post-acute care services and outcomes among elderly stroke patients

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  14. Nicole R. Gonzales, MD,
    15. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board, Neurology

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Carotid revascularization and medical management for asymptomatic carotid stenosis trial (CREST-2) NINDS U01 NS080168 (Brott, Meschia, Lal, Howard) 3/1/2015 - 2/28/2021 Role: Local PI Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit Compared to Standard Management by Emergency Medical Services: The BEST-MSU Study Blind Adjudicator, Vascular Neurologist 11/1/17-11/1/21 Role: Local Co-I

    Research Support, Academic Entities:

    1. Developing a Biochemical Test to Differentiate Cerebral Amyloid Angiopathy-Intracerebral Hemorrhage from Hypertensive Hemorrhage (Gonzales, Pritzkow Co-PIs) 3/1/2019-2/28/2020 IGNITE Award Role: Co-PI

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  15. Brian Kaskie, PhD,
    16. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  16. Pooja Khatri, MD, MSc,
    17. Scientific Advisory Boards:

    1. (1) Diamedica (SAB) (2) Lumosa (company medical representative on DSMB)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Stroke, Associate Editor, 2020-current

    Patents:

    1. NONE

    Publishing Royalties:

    1. UpToDate, Inc -- ongoing update to Stroke article

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Lumosa

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Cerenovus (IIS grant) 2) Bayer (National PI effort) 3) Nervive (NIH SBIR grant co-I)

    Research Support, Government Entities:

    1. 1. NIH/NINDS U25, StrokeNET RCC PI 2. NIH/NINDS U01, StrokeNET NCC MPI 3. NIH/NINDS R01, APRISE MPI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  17. Sarah Livesay, DNP, ARNP,
    18. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Stryker NV, Speaker Fees

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. StrokeChallenges, Lombardi Hill LLC

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Secretary, Neurocritical Care Society

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  18. David S. Liebeskind, MD,
    19. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Consultant as Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  19. Jennifer J. Majersik, MD,
    20. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Neurology, Editorial Board Member, 2015-present (2) Stroke, Associate Editor, 2020-present (3) UpToDate, Reviewer, 2018-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Commericial entity, Foldax, Inc

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH/NINDS, 1U24NS107228 - UT StrokeNet, Principal Investigator, 2018-23 (2) NIH/NINDS, 1U24NS107156 - UR NEXT, Mentor, 2018-23 (3) NIH/NICHD, 1R03HD091432 - Co-Investigator, 2017-19

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  20. Asma M. Moheet, MD, MHDS,
    21. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurocritical Care, Editorial Board member, 3 years.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. InTouch Health, telemedicine neurointensivist, 0 years Stock/Stock Options, Medical Equipment & Materials: (1)GE, 0 (2)Moderna, 0 (3)Teladoc Health, 0

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  21. Jose G. Romano, MD,
    22. Scientific Advisory Boards:

    1. 1) Genentech: for role as member of the independent data monitoring committee for the TIMELESS trial. 2) Genentech: for role as member of the Steering Committee of the Potential for rtPA to Improve Stroke with Mild Symptoms (PRISMS) Study. 2) Vycor/NovaVision: for role as member of the Scientific Advisory Board.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Genentech. Principal Investigator Mild and Rapidly Improving Stroke Study (MaRISS) (M1301087). 12/14/11 - 10/31/20. 2) Bristol Myers Squibb (M1800108). Disparities in Stroke Outcomes in patients with Atrial Fibrillation (FLiPER AF). Sub-Investigator (PI T. Rundek). 02/01/17- 01/31/20.

    Research Support, Government Entities:

    1. 1) National Institute on Minority Health and Health Disparities. Transition of Care Stroke Disparity Study (TCSD-S). R01MD012467. Principal Investigator (MPI, co-PI R.L. Sacco, T. Rundek). September 26, 2017- June 30, 2022. 2) National Institute of Neurological Disorders and Stroke. Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD). R01NS084288. Principal Investigator (MPI, co-PI S. Prabhakaran, D.S. Liebeskind). March 1, 2014 - February 28, 2021 (NCE). 3) National Institute of Neurological Disorders and Stroke. Florida Regional Coordinating Center for NINDS Stroke Trials Network. U24NS107267. Principal Investigator (MPI, co-PI R.L. Sacco). August 1, 2018-July 31, 2023.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Vycor/NovaVision

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  22. Nerses Sanossian, MD,
    23. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  23. Lauren H. Sansing, MD, MS,
    24. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NINDS, U01NS113445, PI, 2019-2022 NIH/NINDS R01NS095993, PI, 2016-2021 NIH/NINDS R01NS097728, PI, 2016-2021

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Heart Association, 19EIA34770133, PI, 2019-2024

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  24. Brian Silver, MD,
    25. Scientific Advisory Boards:

    1. 1. National Institutes of Health StrokeNet study section 2. Women's Health Initiative

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Transcranial magentic stimulation helmet

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Best Doctors, Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Medicolegal expert review, 2005-present

  25. Alexis N. Simpkins, MD, PhD, MS,
    26. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. eNeurologicalSci, Assistant Editor, 2

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  26. Wade Smith, MD, PhD,
    27. Scientific Advisory Boards:

    1. (1) DAWN and ATLAS DMSB- Stryker

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. Cranial Accelerometry and the detection of large vessel stroke

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) U24NS107229, CO-PI, 2018-2023 Stock/Stock Options, Medical Equipment & Materials: Founder, MindRhythm, Inc

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  27. David L. Tirschwell, MD, MSc,
    28. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Abbott, speaker honoraria, unrelated to topic

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1) Abbott, consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Abbott Biogen

    Research Support, Government Entities:

    1. NINDS, U01 NS095869, co-PI, 2017-21 NIH, 1D43TW009137, co-PI, 2019-24 CDC/WA DOH, N21529, consultant, 2019-2020

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  28. David Z. Wang, DO,
    29. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board member: Stroke and Vascular Neurology, Journal of Stroke and Cerebrovascular Disease

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  29. Dileep R. Yavagal, MD and
    30. Scientific Advisory Boards:

    1. Commercial or non-profit entity: Poseydon, Neural analytics

    Gifts:

    1. 1. Medtronic, Inc 2. Cerenovus 3. Rapid Medical 4. Vascular Dynamics

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1. Interventional Neurology, Editorial advisory Board member 2.Frontiers in Endovascular Neurology, Associate Editor, 2010 till date

    Patents:

    1. Continuous Automated Suction Device. This is a endotracheal suction and intubation device for intubated patient on a ventilator.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant to: 1. Medtronic 2. Cerenovus 3. Rapid Medical 4. Neuralanalytics 5. Vascular Dynamics 6. Deck Therapeutics 7. Inneuroco, Inc 8. GLG consulting 9. Guidepoint consulting’ 10. Mosaic consulting 11. Poseydon Medical, LLC. 12. Neurosave 13. Magellan Research Group, LLC.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. Clinical procedure/imaging study: Stroke Mechanical Thrombectomy

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. a. Miami Clinical Translational Science Institute (CTSI) Pilot Study Award for study titled: Time Window of Intracarotid Mesenchymal Stem Cell Therapy in a Large Animal Model of Stroke. This grant is awarded by the NIH funded CTSI program at the University of Miami Miller School of Medicine. ,PI, 1/2013- 12/2013: b.James & Esther King Biomedical Research Program Grant for the study titled Intra-arterial Mesenchymal Stem Cell Delivery in a Canine Model of Acute Ischemic Stroke: PI,2011-2014: This is a competitive grant for $500,000.00 c. James & Esther King Biomedical Research Program Shared Instrumentation Grant (SIG), 2010 Hare, Heldman and Yavagal: Co-PI, 2010. This is a competitive grant for $1000,000.00

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. 1. Goldberg Segala: 2018-2019 2.Eadie Hill Trial Lawyers, LLC: 2018, 2019 3. Rourke and Blumenthal: 2019, 4. Salta Mongeluzzi Barrett & Ben 2019 5. Nelson Mullins Riley & Scarborogh, 2019 6. Arnold Torado Welch & Foliona Co., LPA, 2019 7. Deutsch & Blumberg, PA, 2019, 2020 6. Colson Hicks Eidson, 2019 7. Carnival Cruise Lines, 2019

  30. Bradford B. Worrall, MD, MSc
    31. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology: Associate Editor 1 July 2009 - September 2015; Deputy Editor October 2015 - present

    Patents:

    1. NONE

    Publishing Royalties:

    1. Chapter Author for Merritt's Neurology editions 10, 11, and 12.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. AegisCN, LLC/Duke Clinical Research Institute - Serving as a site for phase II clinical trial titled

    Research Support, Government Entities:

    1. NINDS/NIH – U24 NS107222 (co-Principal Investigator) 2018- 2023 NIH/NCATS – U54 TR002586 (co-Principal Investigator KL2) 2018-2023 NINDS/NIH - R21 NS106480 (Principal Investigator) 2018- 2020 NINDS/NIH - R01 NS 069763 (co-investigator) 2010-2017

    Research Support, Academic Entities:

    1. University of Virginia - CENTERS OF EXCELLENCE CLINICAL RESEARCH GRANT SUPPORT - The UVA BRAIN AND AORTIC ANEURYSM SCREENING (BAAS) study - Principal Investigator 10/13-4/17

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurology, Neurosurgery & Epidemiology (E.C.L.), University of Iowa, Iowa City, IA; Cerebrovascular Center (A.N.R.), Cleveland Clinic, OH; Department of Neurology (J.B.), Loyola University Chicago, Maywood, IL; Department of Neurology (D.L.B.), University of Michigan, Ann Arbor, MI; Department of Neurology (C.D.B.), Wake Forest School of Medicine, Winston-Salem, NC; Stroke Unit (V.C.), University of Perugia, Italy; Department of Neurology (A.C.), Hospital Clinic, Barcelona, Spain; Department of Neurology (C.J.C., D.L.T.), University of Washington, Seattle, WA; Department of Neurology (S.C.-F.), Texas Tech University, El Paso, TX; Departments of Neurology & Epidemiology (M.S.V.E.), Columbia University, New York, NY; Department of Neurological Sciences (P.F.), University of Nebraska, Omaha, NE; Department of Neurology & Neurosurgery (M.T.F.), Vanderbilt University, Nashville, TN; Department of Neurology (L.B.G.), University of Kentucky, Lexington, KY; Department of Neurology (N.R.G.), McGovern Medical School at UTHealth, Houston, TX; Department of Health Management and Policy (B.K.), University of Iowa, Iowa City, IA; Department of Neurology (P.K.), University of Cincinnati, OH; Department of Adult Health & Gerontology Nursing (S.L.), Rush University, Chicago, IL; Department of Neurology (D.S.L.), UCLA; Department of Neurology (J.J.M.), University of Utah, Salt Lake City, UT; Neurocritical Care, OhioHealth Riverside Methodist Hospital (A.M.M.), Columbus, OH; Department of Neurology (J.G.R.), University of Miami, FL; Department of Neurology (N.S.), University Southern California, Los Angeles, CA; Department of Neurology (L.H.S.), Yale School of Medicine, New Haven, CT; Department of Neurology (B.S.), University of Massachusetts, Worcester, MA; Department of Neurology (A.N.S.), University of Florida, Gainesville, FL; Department of Neurology (W.S.), UCSF; Department of Neurology (D.Z.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology & Neurosurgery (D.R.Y.), University of Miami, FL; and Department of Neurology (B.B.W.), University of Virginia, Charlottesville, VA.
  1. Correspondence
    Dr. Leiraenrique-leira{at}uiowa.edu
View Full Text

Article usage

Article usage: May 2020 to March 2023

AbstractFullPdfSource
May 202052840228Highwire
Jun 20201499060Highwire
Jul 202014779559Highwire
Aug 20206623522Highwire
Sep 20206903522Highwire
Oct 20205264122Highwire
Nov 20205352219Highwire
Dec 20205102921Highwire
Jan 2021387178Highwire
Feb 20214872016Highwire
Mar 20214521919Highwire
Apr 2021462104Highwire
May 2021384158Highwire
Jun 2021370109Highwire
Jul 202127582Highwire
Aug 2021261169Highwire
Sep 202120483Highwire
Oct 202131385Highwire
Nov 202130793Highwire
Dec 202118666Highwire
Jan 2022201107Highwire
Feb 202219184Highwire
Mar 202223953Highwire
Apr 202228140Highwire
May 202218175Highwire
Jun 202214452Highwire
Jul 202210832Highwire
Aug 202214030Highwire
Sep 202214820Highwire
Oct 202213350Highwire
Nov 202216841Highwire
Dec 202215231Highwire
Jan 202312551Highwire
Feb 202315761Highwire

Cited By...

Letters: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles